Focused analysis of exome sequencing data for rare germline mutations in familial and sporadic lung cancer

Journal of Thoracic Oncology

Volumn 11, Issue 1, 2016, Pages 52-61

  Liu, Yanhong ^a   Kheradmand, Farrah ^a   Davis, Caleb F ^a   Scheurer, Michael E ^a   Wheeler, David ^a   Tsavachidis, Spiridon ^a   Armstrong, Georgina ^a   Simpson, Claire ^b   Mandal, Diptasri ^c   Kupert, Elena ^d   Anderson, Marshall ^e   You, Ming ^e   Xiong, Donghai ^e   Pikielny, Claudio ^f   Schwartz, Ann G ^g   Bailey Wilson, Joan ^h   Gaba, Colette ⁱ   De Andrade, Mariza ^j   Yang, Ping ^j   Pinney, Susan M ^d   Amos, Christopher I ^f   Spitz, Margaret R ^a   more..

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^d UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^e MEDICAL COLLEGE OF WISCONSIN   (United States)

^f DARTMOUTH COLLEGE   (United States)

^g WAYNE STATE UNIVERSITY   (United States)

^h National Human Genomics Research Institute   (United States)

ⁱ MEDICAL COLLEGE OF OHIO   (United States)

^j MAYO CLINIC   (United States)

more..

Author keywords

Chronic obstructive pulmonary disease; Exome sequencing; Familial; Lung cancer; Single nucleotide variants; Sporadic

Indexed keywords

COILED COIL DOMAIN CONTAINING 147 PROTEIN; DOPAMINE BETA MONOOXYGENASE; EGL 9 FAMILY HYPOXIA INDUCIBLE FACTOR 2; F BOX PROTEIN 38; INSULINASE; IRON RESPONSIVE ELEMENT BINDING PROTEIN NEURONAL 2; LYSINE TRANSFER RNA LIGASE; NICOTINIC RECEPTOR ALPHA5; NICOTINIC RECEPTOR BETA4; NIDOGEN 2; PANTOTHENATE KINASE 1; PATATIN LIKE PHOSPHOLIPASE DOMAIN CONTAINING 8 PROTEIN; TENSIN 1; TROPOMYOSIN; UNCLASSIFIED DRUG; TUMOR MARKER;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; EXOME; EXON; FAMILIAL CANCER; FEMALE; FIRST DEGREE RELATIVE; GENE FREQUENCY; GENE LOCUS; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GERMLINE MUTATION; HUMAN; HUMAN TISSUE; LARGE CELL CARCINOMA; LUNG ADENOCARCINOMA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON SMALL CELL LUNG CANCER; OPEN READING FRAME; PHENOTYPE; PRIORITY JOURNAL; SMALL CELL LUNG CANCER; SMOKING; SOMATIC MUTATION; SQUAMOUS CELL LUNG CARCINOMA; ADENOCARCINOMA; CANCER STAGING; COHORT ANALYSIS; COMPARATIVE STUDY; FOLLOW UP; GENETIC PREDISPOSITION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; LUNG TUMOR; PATHOLOGY; PROGNOSIS; SQUAMOUS CELL CARCINOMA;

ADENOCARCINOMA; ADULT; AGED; BIOMARKERS, TUMOR; CARCINOMA, LARGE CELL; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; EXOME; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GERM-LINE MUTATION; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PHENOTYPE; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMALL CELL LUNG CARCINOMA; SMOKING;

EID: 84959355448     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1016/j.jtho.2015.09.015     Document Type: Article

References (39)

1. Etzel CJ, Kachroo S, Liu M, et al. Development and validation of a lung cancer risk prediction model for African-Americans. Cancer Prev Res (Phila). 2008;1:255-265.
2. Tammemagi CM, Pinsky PF, Caporaso NE, et al. Lung cancer risk prediction: Prostate, Lung, Colorectal And Ovarian Cancer Screening Trial models and validation. J Natl Cancer Inst. 2011;103:1058-1068.
3. Rivas MA, Beaudoin M, Gardet A, et al. Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease. Nat Genet. 2011;43:1066-1073.
4. Johansen CT, Wang J, Lanktree MB, et al. Excess of rare variants in genes identified by genome-wide association study of hypertriglyceridemia. Nat Genet. 2010;42:684-687.
5. Kang G, Lin D, Hakonarson H, et al. Two-stage extreme phenotype sequencing design for discovering and testing common and rare genetic variants: efficiency and power. Hum Hered. 2012;73:139-147.
6. Lamina C. Digging into the extremes: a useful approach for the analysis of rare variants with continuous traits? BMC Proc. 2011;5(suppl 9):S105.
7. Li D, Lewinger JP, Gauderman WJ, et al. Using extreme phenotype sampling to identify the rare causal variants of quantitative traits in association studies. Genet Epidemiol. 2011;35:790-799.
8. Bailey-Wilson JE, Amos CI, Pinney SM, et al. A major lung cancer susceptibility locus maps to chromosome 6q23-25. Am J Hum Genet. 2004;75:460-474.
9. Ooi WL, Elston RC, Chen VW, et al. Increased familial risk for lung cancer. J Natl Cancer Inst. 1986;76:217-222.
10. Jonsson S, Thorsteinsdottir U, Gudbjartsson DF, et al. Familial risk of lung carcinoma in the Icelandic population. JAMA. 2004;292:2977-2983.
11. Liu P, Vikis HG, Wang D, et al. Familial aggregation of common sequence variants on 15q24-25.1 in lung cancer. J Natl Cancer Inst. 2008;100:1326-1330.
12. Lee SH, Goswami S, Grudo A, et al. Antielastin autoimmunity in tobacco smoking-induced emphysema. Nat Med. 2007;13:567-569.
13. Grumelli S, Corry DB, Song LZ, et al. An immune basis for lung parenchymal destruction in chronic obstructive pulmonary disease and emphysema. PLoS Med. 2004;1:e8.
14. Shan M, Cheng HF, Song LZ, et al. Lung myeloid dendritic cells coordinately induce TH1 and TH17 responses in human emphysema. Sci Transl Med. 2009;1:4ra10.
15. Lupski JR, Gonzaga-Jauregui C, Yang Y, et al. Exome sequencing resolves apparent incidental findings and reveals further complexity of SH3TC2 variant alleles causing Charcot-Marie-Toothneuropathy. Genome Med. 2013;5:57.
16. Reid JG, Carroll A, Veeraraghavan N, et al. Launching genomics into the cloud: deployment of Mercury, a next generation sequence analysis pipeline. BMC Bioinformatics. 2014;15:30.
17. Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009;25:1754-1760.
18. DePristo MA, Banks E, Poplin R, et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet. 2011;43:491-498.
19. Challis D, Yu J, Evani US, et al. An integrative variant analysis suite for whole exome next-generation sequencing data. BMC Bioinformatics. 2012;13:8.
20. Kircher M, Witten DM, Jain P, et al. A general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet. 2014;46:310-315.
21. Finn RD, Mistry J, Schuster-Bockler B, et al. Pfam: clans, web tools and services. Nucleic Acids Res. 2006;34(database issue):D247-D251.
22. Attwood TK, Bradley P, Flower DR, et al. PRINTS and its automatic supplement, prePRINTS. Nucleic Acids Res. 2003;31:400-402.
23. Stark C, Breitkreutz BJ, Reguly T, et al. BioGRID: a general repository for interaction datasets. Nucleic Acids Res. 2006;34(database issue):D535-D539.
24. Kelley LA, Sternberg MJ. Protein structure prediction on the Web: a case study using the Phyre server. Nat Protoc. 2009;4:363-371.
25. Lan Q, Hsiung CA, Matsuo K, et al. Genome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia. Nat Genet. 2012;44:1330-1335.
26. Hancock DB, Eijgelsheim M, Wilk JB, et al. Meta-analyses of genome-wide association studies identify multiple loci associated with pulmonary function. Nat Genet. 2010;42:45-52.
27. Genome-wide meta-analyses identify multiple loci associated with smoking behavior. Nat Genet. 2010;42:441-447.
28. Ramsay AJ, Quesada V, Foronda M, et al. POT1 mutations cause telomere dysfunction in chronic lymphocytic leukemia. Nat Genet. 2013;45:526-530.
29. Robles-Espinoza CD, Harland M, Ramsay AJ, et al. POT1 loss-of-function variants predispose to familial melanoma. Nat Genet. 2014;46:478-481.
30. Bainbridge MN, Armstrong GN, Gramatges MM, et al. Germline mutations in shelterin complex genes are associated with familial glioma. J Natl Cancer Inst. 2015;107:384.
31. Siedlinski M, Cho MH, Bakke P, et al. Genome-wide association study of smoking behaviours in patients with COPD. Thorax. 2011;66:894-902.
32. Shiels MS, Huang HY, Hoffman SC, et al. A communitybased study of cigarette smoking behavior in relation to variation in three genes involved in dopamine metabolism: catechol-o-methyltransferase (COMT), dopamine beta-hydroxylase (DBH) and monoamine oxidase-A (MAO-A). Prev Med. 2008;47:116-122.
33. Freire MT, Marques FZ, Hutz MH, et al. Polymorphisms in the DBH and DRD2 gene regions and smoking behavior. Eur Arch Psychiatry Clin Neurosci. 2006;256:93-97.
34. Zhang XY, Chen da C, Xiu MH, et al. Association of functional dopamine-beta-hydroxylase (DBH) 19 bp insertion/deletion polymorphism with smoking severity in male schizophrenic smokers. Schizophr Res. 2012;141:48-53.
35. Wilk JB, Walter RE, Laramie JM, et al. Framingham Heart Study genome-wide association: results for pulmonary function measures. BMC Med Genet. 2007;8(suppl 1):S8.
36. Kathiresan S, Manning AK, Demissie S, et al. A genome-wide association study for blood lipid phenotypes in the FraminghamHeart Study. BMC Med Genet. 2007;8(suppl 1):S17.
37. Kuk C, Gunawardana CG, Soosaipillai A, et al. Nidogen-2: a new serum biomarker for ovarian cancer. Clin Biochem. 2010;43:355-361.
38. Cheng ZX, Huang XH, Wang Q, et al. Clinical significance of decreased nidogen-2 expression in the tumor tissue and serum of patients with hepatocellular carcinoma. J Surg Oncol. 2012;105:71-80.
39. Guerrero-Preston R, Soudry E, Acero J, et al. NID2 and HOXA9 promoter hypermethylation as biomarkers for prevention and early detection in oral cavity squamous cell carcinoma tissues and saliva. Cancer Prev Res (Phila). 2011;4:1061-1072.